Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19
Clinical trial NCT01864889 · UNKNOWN
Trial details
- NCT number
- NCT01864889
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2017-04-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.